Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells-Reference-Cited by-同舟云学术

Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

Published:2011-01-19 Issue:7330 Volume:469 Page:362-367
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Notta Faiyaz,Mullighan Charles G.,Wang Jean C. Y.,Poeppl Armando,Doulatov Sergei,Phillips Letha A.,Ma Jing,Minden Mark D.,Downing James R.,Dick John E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09733.pdf

Reference34 articles.

1. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000)

2. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976)

3. Barrett, M. T. et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nature Genet. 22, 106–109 (1999)

4. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010)

5. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010)

Cited by 407 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model;Pediatric Hematology and Oncology;2024-04-22

2. Chronic arsenic exposure induces malignant transformation of human HaCaT cells through both deterministic and stochastic changes in transcriptome expression;Toxicology and Applied Pharmacology;2024-03

3. Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy;Cancers;2023-11-15

4. BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia;Leukemia;2023-11-09

5. Drug repurposing a compelling cancer strategy with bottomless opportunities;Indian Journal of Pharmacology;2023-09